Home » Topics » Regulatory

Regulatory
RSS

FDA issues approvable letter for UroXatral

Oct. 15, 2001

Novel combinations claimed by Merck Frosst for depression and anxiety

Oct. 11, 2001

Clinically used pain medication now claimed for IBS

Oct. 11, 2001

Biovail files NDA for FlashDose version of fluoxetine

Oct. 5, 2001

FDA approves Entocort EC for treatment of Crohn's disease

Oct. 5, 2001

Phase II trial to compare two ciprofloxacin formulations for urinary tract infections

Oct. 4, 2001

Atrix submits NDA for Leuprogel Three-Month Depot for prostate cancer

Sep. 28, 2001

sBLA submitted for ARANESP

Sep. 25, 2001

New strength of Zomig-ZMT approved by FDA

Sep. 21, 2001

More flexible and personalized therapy now possible with NeoRecormon

Sep. 20, 2001